Sumatriptan oral spray - SUDA

Drug Profile

Sumatriptan oral spray - SUDA

Alternative Names: NVD-201; SUDA-001

Latest Information Update: 09 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NovaDel Pharma
  • Developer SUDA
  • Class Antimigraines; Indoles; Small molecules; Sulfonamides; Tryptamines
  • Mechanism of Action Serotonin 1D receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Migraine

Most Recent Events

  • 09 Feb 2016 Sumatriptan oral spray is still in clinical trial for Migraine
  • 22 Aug 2013 This programme is still active
  • 13 Aug 2013 SUDA Ltd acquires NovaDel Pharma's assets
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top